Drug Development, Insurance Coverage and Processing and Pharmaceutical Companies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Development

Insurance Coverage and Processing

Pharmaceutical Companies

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

SEPTEMBER 6, 2023

To help financially weak citizens gain access to affordable healthcare, the Pradhan Mantri Jan Arogya Yojana (PMJAY) was launched in 2018, providing about 500 million Indians with a ₹5 lakh family health insurance cover that include coverage for 1,400 medical procedures as well as critical diseases like prostate cancer.

Insurance Coverage and Processing

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing

External control arms and debunking real-world data myths

pharmaphorum

AUGUST 31, 2021

However, like many other emerging healthcare technologies, they have been slow to gain traction and there is still confusion and scepticism around ECAs, stemming from a lack of precedence, step-by-step guidance and data to quantify their impact on drug development costs and clinical outcomes.

Insurance Coverage and Processing

Insurance Coverage and Processing Drug Development Documentation Labelling

Pharmacist Digest

Is India capable of ensuring equitable access to biopharmaceuticals?

External control arms and debunking real-world data myths

Stay Connected